About ReproUnion

Reproductive Medicine Across Borders

ReproUnion is a cross-border collaboration between Sweden and Denmark within the area of reproductive medicine in the Øresund Region. More than 50 professors and researchers work across disciplines to drive research in the underlying reasons of infertility and to optimize fertility treatment and Innovation. Public-private partnerships like ReproUnion are an important part of the solution to the challenges facing our healthcare systems. It´s about innovation and growth, but first and foremost it´s about putting patients´ needs first!

ReproUnion is a growing partnership where academia, the healthcare sector, and the life science industry are joining forces to provide the best care with the most modern technologies to infertility patients in the region. The project is an outstanding example of how we can work together across borders and disciplines to create the best possible conditions for life science research and innovation based on one of the region’s scientific strongholds.

ReproUnion is funded by EU Interreg Interreg Öresund-Kattegat-Skagerrak, the Capital Region of Denmark, Region Skåne and Ferring Pharmaceuticals.

The story of a decade with successful collaboration

The Øresund Region – also known as the Medicon Valley – has a high international position within reproductive medicine and is by many considered to be a frontrunner in the field. During 15 years, the region has developed and gained momentum from ReproSund through ReproHigh and ReproUnion with funding from EU Interreg programmes.

  • ReproSund (2010-2013)
  • ReproHigh (2012-2014): ‘Oresund Award in Health from the Capital Region of Denmark and the Region Skane.
  • ReproUnion 1.0 (2015-2018): Funding of 22 ph.d./postdoc projects.
  • ReproUnion 2.0 (2019-2022): Building fertility awareness and establishing the ReproUnion Biobank & Infertlity Cohort.
  • ReproUnion 3.0 (2023-2026): Developing a Platform for Driving Reproductive Health Innovation.

HERE you can watch a film about ReproUnion from 2022!

The Vision

Our vision is to become a world leader in overcoming infertility by forming a strong private-public partnership involving the public hospitals, academic research institutions and the life science industry. It is ambitious but not unrealistic. We will accomplish our vision by focusing on prevention, treatment and further research in reproductive medicine, as well as on education and career development with the ReproUnion Management Unit as one point of entry for partners, researchers, and companies. This will ensure greater efficiency, higher academic standards, and a more effective use of our common resources.